Shares of Spire Healthcare Group plc (LON:SPI - Get Free Report) shot up 14.1% during mid-day trading on Saturday . The stock traded as high as GBX 256.50 ($3.47) and last traded at GBX 247 ($3.34). 9,747,062 shares changed hands during trading, an increase of 563% from the average session volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.93).
Analysts Set New Price Targets
SPI has been the subject of several research analyst reports. JPMorgan Chase & Co. lowered their price target on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating for the company in a research report on Tuesday, August 5th. Berenberg Bank restated a "buy" rating and set a GBX 280 price target on shares of Spire Healthcare Group in a research report on Thursday, July 31st. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock has a consensus rating of "Buy" and an average price target of GBX 294.33.
Get Our Latest Research Report on SPI
Spire Healthcare Group Stock Performance
The firm has a market capitalization of £985.81 million, a PE ratio of 5,326.09, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The firm has a 50-day moving average price of GBX 218.99 and a 200 day moving average price of GBX 203.96. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25.
Spire Healthcare Group (LON:SPI - Get Free Report) last released its earnings results on Thursday, July 31st. The company reported GBX 4.10 earnings per share (EPS) for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. Research analysts expect that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.
About Spire Healthcare Group
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
See Also
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.